Judge Profile

Steen Lyders Wadskov

4 IP cases indexed. Covers patent matters.

Cases Presided Over

4 cases indexed | Page 1 of 1

patent dismissed · Apr 22, 2025

Pfizer Inc. v.GlaxoSmithKline Biologicals SA

Milan (IT) Central Division- Section · App_16366/2025

In this procedural order, the Unified Patent Court allowed Pfizer and GlaxoSmithKline Biologicals SA to withdraw a revocation action concerning EP4183412. The case involved complex cross-referencing between an infringement proceeding in Düsseldorf and the revocation action in Milan. Since both parties agreed on the withdrawal and subsequent closure of the proceedings, the court granted the request while also ordering the reimbursement of 60% of the court fees paid by the withdrawing parties.

patent dismissed · Apr 22, 2025

Pfizer Inc. v.GlaxoSmithKline Biologicals SA

Milan (IT) Central Division- Section · App_17784/2025

In a procedural order, the UPC Central Division allowed Pfizer (the claimants/counterclaimants) to withdraw its revocation action against GlaxoSmithKline Biologicals SA concerning EP4183412. This decision was reached following mutual agreement between both parties. The Court also ordered the reimbursement of 60% of court fees paid by the withdrawing parties. This case highlights how procedural agreements and party consent can lead to the swift closure of complex patent litigation.

patent dismissed · Apr 22, 2025

Pfizer Inc. v.GlaxoSmithKline Biologicals SA

Milan (IT) Central Division- Section · App_17656/2025

In a procedural order concerning EP4183412, the UPC Central Division allowed Pfizer (the claimants) and GlaxoSmithKline Biologicals SA (the defendant) to withdraw their respective revocation action and counterclaim. The parties reached an agreement that rendered the patent amendment applications moot. This case highlights how mutual consent can lead to the swift closure of complex litigation in the UPC, even when significant value is at stake.

patent dismissed · Apr 22, 2025

Pfizer Inc. v.GlaxoSmithKline Biologicals SA

Milan (IT) Central Division- Section · App_17607/2025

In a procedural order concerning the revocation of EP4183412, Pfizer and GlaxoSmithKline Biologicals SA mutually agreed to withdraw the action and counterclaim. The UPC Central Division granted this request, effectively closing the proceedings. This case highlights how mutual consent can lead to the swift dismissal of complex patent litigation, even when significant value is at stake.

Arctic Invent — IP Strategy

Facing a similar IP matter?

Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.

Consult our team →